Direkt zum Inhalt
Merck

Antimicrobial susceptibilities of clinical isolates of HACEK organisms.

Antimicrobial agents and chemotherapy (2013-02-14)
Bryan Coburn, Baldwin Toye, Prasad Rawte, Frances B Jamieson, David J Farrell, Samir N Patel
ZUSAMMENFASSUNG

The "HACEK" organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinical HACEK isolates to 18 antimicrobials. All isolates were susceptible to ceftriaxone and levofloxacin, indicating that these agents remain appropriate empirical choices for the treatment of infections with this group of organisms.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Ceftriaxon Dinatriumsalz Hemi(heptahydrat), third-generation cephalosporin antibiotic
Supelco
Levofloxacin, analytical standard
Supelco
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ofloxacin, VETRANAL®, analytical standard
Ceftriaxon-Natrium, European Pharmacopoeia (EP) Reference Standard
Ofloxacin, European Pharmacopoeia (EP) Reference Standard